Both Newfield Exploration and Pioneer Natural Resources are trading near trendline resistance, and a...
Buy AmBev (ABV)
01/12/2010 4:35 pm EST
AmBev, or to give the company its full name Companhia de Bebidas Das Americas (ABV), is the largest beer company in Brazil and the fourth largest beer company in the world.
Its 70% market share in Brazil gives it huge exposure to growth in that country’s domestic economy. And Brazil isn’t a bad beer market to dominate. Beer consumption is forecast to grow by 22% in Brazil from 2008-2015, which ranks Brazil as the second fastest growing beer market in the world behind China.
Through its 100% ownership of Quinsa, AmBev sells the leading brands in Argentina, Uruguay, Paraguay, and Bolivia. AmBev owns Canada’s Labatt. The company is also the largest Pepsi bottler outside the United States, which gives AmBev huge volumes to feed through its distribution system.
Those volumes plus huge market shares plus a rigorous cost-cutting culture have made AmBev one of the most profitable beer companies in the world with a huge 37.8% core operating margin in 2008. That’s 15 to 20 percentage points higher than at competitors, according to Morningstar.
AmBev is controlled by AB AmBev (AHBIF.PK), the largest brewer in the world. (InBev looks like it will soon acquire full control of Mexico’s Grupo Modelo, which will give the combined companies increased clout in heading off any challenge from Heineken, which has just bought Mexican brewer Femsa. Femsa sells the Bavaria, Sol, and Kaiser brands in Brazil.) InBev owns 84% of the voting stock. The two companies trade as separate public companies. AMBev shares currently pay a dividend of a little more than 2%.
As of January 13, I’ll be adding these shares to Jubak’s Picks with a target price of $118 by October 2010.
Full disclosure: I don’t own shares of any stock mentioned in this post. I will buy shares of AmBev three days after this is posted.
Related Articles on STOCKS
Anavex (AVXL) is a biopharmaceutical company dedicated to the development of novel drug candidates t...
Back in October we suggested investors keep an open mind with respect to retailers, which had been b...
Oil companies typically come into favor in mid-December and remain so until late April or early May ...